Trial Profile
Open-label, Single-dose, Parallel-group Study to Compare the PKs of Iloperidone in Subjects With Mild or Moderate Hepatic Impairment With That in Matched Healthy Control Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Iloperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals
- 21 Aug 2012 New trial record